Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page
- Check6 days agoChange Detected- The page now shows Revision: v3.5.4, replacing the prior revision v3.5.3, indicating a routine maintenance/version update to the page rather than a substantive change to the study details.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows an updated revision label, changing from v3.5.2 to v3.5.3. This reflects a new site release without altering the study details or layout.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision note updated to v3.5.2, replacing v3.5.0 on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the page.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed, indicating a metadata version update that does not alter study details or displayed information.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and Revision: v3.4.1 were removed. These updates are administrative and do not affect the study details on the page.SummaryDifference0.3%

Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.